204 related articles for article (PubMed ID: 15208502)
1. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeling morpholinos with 90Y, 111In, 188Re and 99mTc.
Liu CB; Liu GZ; Liu N; Zhang YM; He J; Rusckowski M; Hnatowich DJ
Nucl Med Biol; 2003 Feb; 30(2):207-14. PubMed ID: 12623121
[TBL] [Abstract][Full Text] [Related]
3. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds.
Knapp FF; Guhlke S; Beets AL; Lin WY; Stabin M; Amols H; Weinberger J
Cardiovasc Radiat Med; 1999; 1(1):86-97. PubMed ID: 11272362
[TBL] [Abstract][Full Text] [Related]
4. Amplification targeting: a modified pretargeting approach with potential for signal amplification-proof of a concept.
He J; Liu G; Gupta S; Zhang Y; Rusckowski M; Hnatowich DJ
J Nucl Med; 2004 Jun; 45(6):1087-95. PubMed ID: 15181145
[TBL] [Abstract][Full Text] [Related]
5. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
6. Investigations of 99mTc morpholino pretargeting in mice.
Liu G; Liu C; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2003 Jun; 24(6):697-705. PubMed ID: 12766607
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.
Liu G; Dou S; He J; Yin D; Gupta S; Zhang S; Wang Y; Rusckowski M; Hnatowich DJ
Appl Radiat Isot; 2006 Sep; 64(9):971-8. PubMed ID: 16730997
[TBL] [Abstract][Full Text] [Related]
8. Rhenium-188 labeled recombinant human plasminogen kringle5 (rhk5) and preliminary biodistribution. Evaluation in mice bearing A549 tumours.
Guo R; Ma Y; Zhang R; Liang S; Shen H; Xu H; Li B
Nuklearmedizin; 2011; 50(6):234-9. PubMed ID: 21808809
[TBL] [Abstract][Full Text] [Related]
9. 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution.
Ballot S; Noiret N; Hindré F; Denizot B; Garin E; Rajerison H; Benoit JP
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):602-7. PubMed ID: 16450136
[TBL] [Abstract][Full Text] [Related]
10. 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy.
Das T; Banerjee S; Samuel G; Sarma HD; Ramamoorthy N; Pillai MR
Nucl Med Commun; 2000 Oct; 21(10):939-45. PubMed ID: 11130335
[TBL] [Abstract][Full Text] [Related]
11. Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states.
Garnuszek P; Pawlak D; Maurin M; Jankovic D; Karczmarczyk U; Mikołajczak R
Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):95-100. PubMed ID: 22936501
[TBL] [Abstract][Full Text] [Related]
12. The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice.
Liu G; Zhang S; He J; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 2002 Sep; 46(3):233-43. PubMed ID: 12134139
[TBL] [Abstract][Full Text] [Related]
13. Preparation and imaging of rhenium-188 labeled human serum albumin microsphere in orthotopic hepatoma rats.
Ni HC; Yu CY; Chen SJ; Chen LC; Lin CH; Lee WC; Chuang CH; Ho CL; Chang CH; Lee TW
Appl Radiat Isot; 2015 May; 99():117-21. PubMed ID: 25748057
[TBL] [Abstract][Full Text] [Related]
14. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.
Uehara T; Jin ZL; Ogawa K; Akizawa H; Hashimoto K; Nakayama M; Arano Y
Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464
[TBL] [Abstract][Full Text] [Related]
15. A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.
Liu G; Dou S; Baker S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
Cancer Biol Ther; 2010 Oct; 10(8):767-74. PubMed ID: 21099368
[TBL] [Abstract][Full Text] [Related]
16. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
17. Initial investigations of 99mTc-labeled morpholinos for radiopharmaceutical applications.
Mang'era KO; Liu G; Yi W; Zhang Y; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
Eur J Nucl Med; 2001 Nov; 28(11):1682-9. PubMed ID: 11702111
[TBL] [Abstract][Full Text] [Related]
18. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
20. Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.
Liu G; Dou S; He J; Liu X; Rusckowski M; Hnatowich DJ
Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):237-46. PubMed ID: 17021815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
